Advertisement

Cations and the forearm circulation in hypertensive humans

  • A. Takeshita
  • T. Imaizumi
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 63)

Abstract

Epidemiological studies suggest that excess salt intake contributes to the prevalence of essential hypertension in humans [1]. For the past 15 years, there has been a considerable interest in the effects of excess salt intake on blood pressure and vascular resistance in humans [2–13]. Several important features as to the relationship between excess salt intake and blood pressure in humans have been delineated in these studies. First, it has been clearly shown that effects of dietary salt loading on blood pressure and vascular resistance vary considerably among subjects. Dietary salt loading may produce a marked increase in blood pressure in some but may not alter blood pressure in others [4–6, 11, 13]. Generally speaking, hypertensive patients are more sensitive to dietary salt loading than normotensive subjects [5, 7, 8, 10, 11]. However, it has also been shown that there is a considerable variation in responses to salt loading even among hypertensive patients [4,6,13]. The findings of variable responses to salt loading in humans are consistent with the findings in experimental animals [14-18]. Excess salt intake increases blood pressure and vascular resistance in rats with genetic hypertension but does not alter them in normotensive control rats [14–18].

Keywords

Essential Hypertension Dietary Salt Forearm Blood Flow Lower Body Negative Pressure Normotensive Subject 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Freis ED (1976): Salt, volume and the prevention of hypertension. Circulation 53: 589–596.PubMedGoogle Scholar
  2. 2.
    Abboud FM (1974): Effets of sodium, angiotensin, and steroids on vascular reactivity in man. Fed Proc 33: 143–149.PubMedGoogle Scholar
  3. 3.
    Campese VM, Romoff MS, Levitan D, Saglikes Y, Friedler RM, Massry SG (1982): Abnormal relationship between sodium intake and sympathetic nervous activity in salt-sensitive patients with essential hypertension. Kidney Int 21: 371–378.PubMedCrossRefGoogle Scholar
  4. 4.
    Fujita T, Henry WL, Bartter FC, Lake CR, Delea CS (1980): Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med 69: 334–344.PubMedCrossRefGoogle Scholar
  5. 5.
    Fujita T, Node, Ando K (1984): Sodium susceptibility and potassium effects in young patients with borderline hypertension. Circulation 69: 468–476.PubMedCrossRefGoogle Scholar
  6. 6.
    Kawasaki T, Delea CS, Bartter FC, Smith H (1978): The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med 64: 193–198.PubMedCrossRefGoogle Scholar
  7. 7.
    Kirkendall WM, Connor WE, Abboud FM, Rastogi SP, Anderson TA, Fry M (1976): The effect of dietary chloride on blood pressure, body fluids, electrolytes, renal function, and serum lipids of normotensive man. J Lab Clin Med 87: 418–434.Google Scholar
  8. 8.
    Luft FC, Rankin LI, Bloch R, Weyman AE, Willis LR, Murray RH, Grim CE, Weinberger MH (1979): Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation 60: 697–706.PubMedGoogle Scholar
  9. 9.
    Luft FC, Rankin LI, Henry DP et al. (1979): Plasma and urinary norepinephrine values at extremes of sodium intake in normal man. Hypertension 1: 261–266.PubMedGoogle Scholar
  10. 10.
    Mark AL, Lawton WJ, Abboud FM, Fitz AE, Connor WE, Heistad DD (1975): Effects of high and low sodium intake on arterial pressure and forearm vascular resistance in borderline hypertension. Circ Res 36–37 (suppl): I-194–I-198.Google Scholar
  11. 11.
    Sullivan JM, Ratts TE, Taylor JC, Kraus DH, Barton BR, Patrick DR, Read SW (1980): Hemodynamic effects of dietary sodium in man. A preliminary report. Hypertension 2: 506–514.PubMedGoogle Scholar
  12. 12.
    Takeshita A, Ashihara T, Yamamoto K, Imaizumi T, Hoka S, Ito N, Nakamura M (1984): Venous responses to salt loading in hypertensive subjects. Circulation 69: 50–56.PubMedCrossRefGoogle Scholar
  13. 13.
    Takeshita A, Imaizumi T, Ashihara T, Nakamura M (1982): Characteristics of responses to salt loading and deprivation in hypertensive subjects. Circ Res 51: 457–464.PubMedGoogle Scholar
  14. 14.
    Dahl LK, Heine M, Tassinari L (1962): Effects of chronic salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med 115: 1173–1190.PubMedCrossRefGoogle Scholar
  15. 15.
    Mark AL, Gordon FJ, Takeshita A (1981): Sodium, vascular resistance and genetic hypertension. In: Hypertension, ed. by Brenmer BM and Steun JH, Churchill Livingstone, p. 21–38.Google Scholar
  16. 16.
    Takeshita A, Imaizumi T, Ashihara T, Nakamura M (1982): Adrenergic mechanisms do not contribute to salt-induced vasoconstriction in stroke-prone spontaneously hypertensive rat. Hypertension 4: 288–293.PubMedGoogle Scholar
  17. 17.
    Takeshita A, Mark AL (1978): Neurogenic contribution to hindquarters vasoconstriction during high sodium intake in Dahl strain of genetically hypertensive rats. Circ Res 43 (suppl I): I-86–I-91.Google Scholar
  18. 18.
    Takeshita A, Mark AL, Brody M (1979): Prevention of salt-induced hypertension in the Dahl strain by 6-hydroxydopamine. Am J Physiol 236: H48–H52.PubMedGoogle Scholar
  19. 19.
    Tobian L, Lange J, Azar S, Iwai J, Koop D, Coffee K, Johnson MA (1978): Reduction of natriuretic capacity and renin release in isolated blood perfused kidneys of Dahl hypertensionprone rats. Circ Res 43 (suppl I): I-92–I-98.Google Scholar
  20. 20.
    Takeshita A, Mark AL (1980): Decreased vasodilator capacity of forearm resistance vessels in borderline hypertension. Hypertension 2: 610–615.PubMedGoogle Scholar
  21. 21.
    Folkow B (1971): Haemodynamic consequences of the adaptive structural changes of the resistance vessels in hypertension. Clin Sci 41: 1–12.PubMedGoogle Scholar
  22. 22.
    Tobian L Jr, Binion JT (1952): Tissue cations and water in arterial hypertension. Circulation 5: 754–758.PubMedGoogle Scholar
  23. 23.
    deChamplain J, Krakoff LR, Axelrod J (1968): Relationship between sodium intake and norepinephrine storage during the development of experimental hypertension. Circ Res 23: 479–491.Google Scholar
  24. 24.
    Bohr DF, Seidel C, Sobieski J (1969): Possible role of sodium-calcium pumps in tension development of vascular smooth muscle. Microvasc Res 1: 335–343.PubMedCrossRefGoogle Scholar
  25. 25.
    Hollander W, Shibata N (1968): Mode of action of sodium on the contractile proteins of the arteries. J Clin Invest 47: 47a.CrossRefGoogle Scholar
  26. 26.
    Needleman P, Adams SP, Cole BR, Currie MG, Geller DM, Michener ML, Saper CG, Schwartz D, Standert DG (1985): Atriopeptins as cardiac hormones. Hypertension 7: 469–482.PubMedGoogle Scholar
  27. 27.
    Heistad DD, Abboud FM, Ballard DR (1971): Relationship between plasma sodium concentration and vascular reactivity in man. J Clin Invest 50: 2022–2032.PubMedCrossRefGoogle Scholar
  28. 28.
    Zoller RP, Mark AL, Abboud FM, Schmid PG, Heistad DD (1972): The role of low pressure baroreceptors in reflex vasoconstrictor responses in man. J Clin Invest 51: 2967–2972.PubMedCrossRefGoogle Scholar
  29. 29.
    Guo GB, Abboud FM (1984): Angiotensin II attenuates baroreflex control of heart rate and sympathetic activity. Am J Physiol 246: H80–H89.PubMedGoogle Scholar
  30. 30.
    Imaizumi T, Takeshita A, Higuchi S, Higashi H, Nakamura M (1986): Effects of atrial extract and synthetic atrial natriuretic peptide on arterial baroreflex control of lumbar sympathetic nerve activity. Jap Circ J 50: 1135–1136.Google Scholar
  31. 31.
    Undersser KP, Hasser EM, Haywood JR, Johnson AK, Bishop VS (1985): Interactions of vasopressin with the area postrema in arterial baroreflex function in conscious rabbits. Circ Res 56: 410–417.Google Scholar
  32. 32.
    Coleman TG, Granger HJ, Guyton AC (1971): Whole body circulatory autoregulation and hypertension. Circ Res 28/29 (suppl II): II-76–II-87.Google Scholar
  33. 33.
    Onesti G, Kim KE, Greco JA, Del Guerico ET, Fernandes M, Schwartz C (1975): Blood pressure regulation in end-stage renal disease and anephric man. Circ Res 36 (suppl I): I-145–I-152.Google Scholar
  34. 34.
    Limas C, Westrum B, Limas CJ, Cohn JN (1980): Effect of salt on the vascular lesions of spontaneously hypertensive rats. Hypertension 2: 477–489.PubMedGoogle Scholar
  35. 35.
    Takeshita A, Imaizumi T, Ashihara T, Yamamoto K, Hoka S, Nakamura M (1982): Limited maximal vasodilator capacity of forearm resistance vessels in normotensive young men with a familial predisposition to hypertension. Circ Res 50: 671–677.PubMedGoogle Scholar
  36. 36.
    Fujita T, Ando K (1984): Hemodynamic and endocrine changes associated with potassium supplementation in sodium-loaded hypertensives. Hypertension 6: 184–192.PubMedGoogle Scholar
  37. 37.
    Meneely GR, Ball COT, Youmans JB (1957): Chronic sodium chloride toxicity: Protective effect of added potassium chloride. Ann Intern Med 47: 263–273.PubMedGoogle Scholar
  38. 38.
    Overbeck HW, Derifield RS, Pamnani MB, Sozen T (1974): Attenuated vasodilator responses to K+ in essential hypertensive men. J Clin Invest 53: 678–686.PubMedCrossRefGoogle Scholar
  39. 39.
    Phillips PJW, Robinson BF (1984): The dilator response to K+ ions reduced in the forearm resistance vessels of men with primary hypertension. Clin Sci 66: 237–239.PubMedGoogle Scholar
  40. 40.
    Chen WT, Brace RA, Scott JB, Anderson DK, Haddy FJ (1972): The mechanism of the vasodilator action of potassium. Proc Soc Exp Biol Med 140: 820–824.PubMedGoogle Scholar
  41. 41.
    Hulthén UL, Bolli P, Kiowski W, Bühler FR (1984): Forearm vasoconstrictor response to ouabain: studies in patients with mild and moderate hypertension. J Cardiovasc Pharmacol 6 (suppl): S75–S81.PubMedCrossRefGoogle Scholar
  42. 42.
    Young DB, McCaa RE, Pan YJ, Guyton AC (1976): The natriuretic and hypotensive effects of potassium. Circ Res 38 (suppl II): II-84–II-89.Google Scholar
  43. 43.
    Lund-Johansen P (1970): Hemodynamic changes in long-term diuretic therapy of essential hypertension. Acta Med Scand 187: 509–518.PubMedCrossRefGoogle Scholar
  44. 44.
    Matterson BJ, Oster JR, Michael UF, Bolton SM, Burton ZC, Stambaugh JE, Morledge J (1978): Dose-response to chlorothiazide in patients with mild hypertension. Efficacy of a lower dose. Clin Pharmacol Ther 22: 519–527.Google Scholar
  45. 45.
    Bouthier JA, Safar ME, Levenson JA, Simon A: Hemodynamic effects of a diuretic-like substance on the forearm circulation of men with essential hypertension (personal communication).Google Scholar
  46. 46.
    Khalil FA, Eckstein JW, Horsley AW, Keasling HH (1961): Effects of chlorothazide on forearm vascular responses to norepinephrine. J Appl Physiol 16: 549–552.Google Scholar
  47. 47.
    Robinson BF, Dobbs RJ, Bayley S (1982): Response of forearm resistance vessels to verapamil and sodium nitroprusside in normotensive and hypertensive men: evidence for a functional abnormality of vascular smooth muscle in primary hypertension. Clin Sci 63: 33–42.PubMedGoogle Scholar
  48. 48.
    Robinson BF, Dobbs RJ, Phillips RJW (1983): Effects of treatment with chlorthalidone and atenolol on response to dilator agents in the forearm resistance vessels of men with primary hypertension. Br J Clin Pharmac 16: 327–332.Google Scholar

Copyright information

© Martinus Nijhoff Publishers, Dordrecht. 1987

Authors and Affiliations

  • A. Takeshita
  • T. Imaizumi

There are no affiliations available

Personalised recommendations